Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1979 1
1983 2
1985 1
1989 1
1990 3
1992 2
1993 1
1995 1
1997 2
1998 4
1999 1
2000 1
2001 1
2002 2
2003 5
2004 1
2005 1
2006 3
2008 1
2009 1
2010 1
2011 3
2012 2
2013 3
2014 4
2015 4
2016 1
2017 8
2018 4
2019 6
2020 1
2021 6
2022 7
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group. Howard JF Jr, et al. Among authors: dreier t. Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22. Neurology. 2019. PMID: 31118245 Free PMC article. Clinical Trial.
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans.
Ulrichts P, Guglietta A, Dreier T, van Bragt T, Hanssens V, Hofman E, Vankerckhoven B, Verheesen P, Ongenae N, Lykhopiy V, Enriquez FJ, Cho J, Ober RJ, Ward ES, de Haard H, Leupin N. Ulrichts P, et al. Among authors: dreier t. J Clin Invest. 2018 Oct 1;128(10):4372-4386. doi: 10.1172/JCI97911. Epub 2018 Jul 24. J Clin Invest. 2018. PMID: 30040076 Free PMC article. Clinical Trial.
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
Newland AC, Sánchez-González B, Rejtő L, Egyed M, Romanyuk N, Godar M, Verschueren K, Gandini D, Ulrichts P, Beauchamp J, Dreier T, Ward ES, Michel M, Liebman HA, de Haard H, Leupin N, Kuter DJ. Newland AC, et al. Among authors: dreier t. Am J Hematol. 2020 Feb;95(2):178-187. doi: 10.1002/ajh.25680. Epub 2019 Dec 10. Am J Hematol. 2020. PMID: 31821591 Free PMC article. Clinical Trial.
Classical conditioning of faciliatory paired-pulse TMS.
Ewers SP, Dreier TM, Al-Bas S, Schwenkreis P, Pleger B. Ewers SP, et al. Among authors: dreier tm. Sci Rep. 2023 Apr 16;13(1):6192. doi: 10.1038/s41598-023-32894-w. Sci Rep. 2023. PMID: 37062779 Free PMC article.
X-ray in-line holography and holotomography at the NanoMAX beamline.
Kalbfleisch S, Zhang Y, Kahnt M, Buakor K, Langer M, Dreier T, Dierks H, Stjärneblad P, Larsson E, Gordeyeva K, Chayanun L, Söderberg D, Wallentin J, Bech M, Villanueva-Perez P. Kalbfleisch S, et al. Among authors: dreier t. J Synchrotron Radiat. 2022 Jan 1;29(Pt 1):224-229. doi: 10.1107/S1600577521012200. Epub 2022 Jan 1. J Synchrotron Radiat. 2022. PMID: 34985439 Free PMC article.
86 results